ITUB4:BMFBOVESPAItau Unibanco Holding SA Pfd Analysis
Data as of 2026-06-19 - not real-time
R$40.49
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Itaú Unibanco (ITUB4) is trading at BRL 40.49, comfortably above its 20‑day SMA of 39.86 but still below the 50‑day (41.83) and 200‑day (40.83) averages, indicating a neutral price stance. The RSI of 50.96 and a bullish MACD histogram (+0.288) suggest modest momentum without overbought pressure. Support at BRL 38.43 and resistance at BRL 41.63 frame the near‑term range, leaving roughly 3% upside to the resistance level. Valuation metrics are compelling: a trailing PE of 9.8 versus an industry average of 16.9 and an upside potential of 19.5% based on analyst targets (mean BRL 48.38, median BRL 50). Fundamental strength is underscored by an operating margin of 33%, ROE of 21.8% and a forward EPS of 5.16, translating to a forward PE of 7.8. The recent Q1 earnings call material (released 24 days ago) highlighted continued cash generation (BRL 531 bn) and stable loan growth despite a 2.1% revenue dip.
Market sentiment is extremely bullish, reflected by a Fear‑Greed Index of 90.7, yet the stock’s 30‑day volatility of 23.3% and low beta (0.02) indicate price swings that are largely idiosyncratic. The balance sheet shows ample liquidity, though total debt exceeds cash, the bank’s strong capital ratios and low regulatory exposure in Brazil mitigate solvency concerns. Given the undervalued pricing, solid profitability and analyst consensus of “strong buy,” the recommendation is to buy on both short‑ and medium‑term horizons, with a higher conviction for longer‑term ownership. Investors should monitor the BRL 38.43 support and any macro‑policy shifts in Brazil that could affect credit quality, but the current risk profile is moderate (overall risk score 5/10).
Market sentiment is extremely bullish, reflected by a Fear‑Greed Index of 90.7, yet the stock’s 30‑day volatility of 23.3% and low beta (0.02) indicate price swings that are largely idiosyncratic. The balance sheet shows ample liquidity, though total debt exceeds cash, the bank’s strong capital ratios and low regulatory exposure in Brazil mitigate solvency concerns. Given the undervalued pricing, solid profitability and analyst consensus of “strong buy,” the recommendation is to buy on both short‑ and medium‑term horizons, with a higher conviction for longer‑term ownership. Investors should monitor the BRL 38.43 support and any macro‑policy shifts in Brazil that could affect credit quality, but the current risk profile is moderate (overall risk score 5/10).
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD histogram
- Price near support with room to resistance
- Undervalued PE vs peers
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward PE of 7.8 indicating growth
- Analyst target median BRL 50
- Strong ROE and operating margins
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust cash generation and capital base
- Low beta reducing market correlation
- Consistent profitability and capital appreciation focus
Key Metrics & Analysis
Financial Health
Revenue Growth-2.10%
Profit Margin33.28%
P/E Ratio9.8
ROE21.82%
ROA1.57%
P/B Ratio2.1
Op. Cash FlowR$21.2B
Industry P/E16.9
Technical Analysis
TrendNeutral
RSI51.0
SupportR$38.43
ResistanceR$41.63
MA 20R$39.86
MA 50R$41.83
MA 200R$40.83
MACDBullish
VolumeStable
Fear & Greed Index90.7
Valuation
Target PriceR$48.38
Upside/Downside19.50%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.02
Volatility23.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.